Meeting
2015 ASCO Annual Meeting
In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy.
Authors
Thomas Urban Marron
Mount Sinai Hospital, New York, NY
Thomas Urban Marron , Adam Binder , Nina Bhardwaj , Seunghee Kim-Schulze , Tibor Keler , Tom Davis , Elizabeth Crowley , Andres M. Salazar , Joshua Brody
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics and Translational Research
Sub Track
Vaccines
Clinical Trial Registration Number
NCT01976585
Citation
J Clin Oncol 33, 2015 (suppl; abstr TPS3105)
DOI
10.1200/jco.2015.33.15_suppl.tps3105
Abstract #
TPS3105
Poster Bd #
422a
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
A phase II open labeled, randomized study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared to Montanide, in melanoma patients in complete clinical remission.
First Author: Anna C. Pavlick
Poster
2023 ASCO Genitourinary Cancers Symposium
Peripheral blood immune cell profiling in survivors of testicular germ cell tumors.
First Author: Michal Chovanec
Poster
2014 ASCO Annual Meeting
Intratumoral vaccination with activated allogeneic dendritic cells in patients with newly diganosed metastatic renal cell carcinoma (mRCC).
First Author: Anders Magnusson
Poster
2014 Gastrointestinal Cancers Symposium
The effect of stress on efficacy of dendritic cell therapy for esophageal squamous cell carcinoma.
First Author: Yasunori Akutsu